Research articleDual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma
Introduction
In the last decades, treatment approaches for larynx and hypopharynx squamous cell carcinoma (L/H SCC) have shifted toward organ-preserving strategies, with the aim of limiting functional impairments associated with total laryngectomy/pharyngolaryngectomy and improving patients’ quality of life [1]. While organ-preserving trials have provided strong evidence that well-selected patients with L/H SCC may benefit from organ-preservation strategies, there remains substantial controversy on the optimal management of these patients [2]. In fact, despite improvement in radiotherapy techniques and systemic treatments, relapse rates in locally advanced L/H SCC after organ-preserving treatment remain high, with rates of loco-regional recurrence (LRR) at 5 years reaching 30–40% [[3], [4], [5]]. In addition, observational data suggest that 5-year survival rates of L/H SCC have decreased [6].
Better tumor characterisation through use of imaging biomarkers has the potential to provide insightful information for outcome prediction and treatment selection in L/H SCC. Various functional imaging modalities assessing tumor metabolism, hypoxia, cellularity and perfusion have been investigated in HNC. These modalities notably comprise the use of positron emission tomography (PET), including 18F- fluorodeoxyglucose (FDG-PET) [[7], [8], [9]], 18F-fluoromisonidazole-PET (FMISO-PET) [8,10] or 18-F-fluoroazomycin arabinoside-PET (FAZA-PET) [11]; use of magnetic resonance imaging (MRI), including diffusion weighted imaging [12,13] or dynamic contrast-enhance MRI [11,12]; as well as use of CT perfusion imaging [14,15]. Assessment of tumor perfusion in HNC is considered a useful tool for non-invasive evaluation of intra-tumoral microvessel density and for characterisation of tumor angiogenesis [16,17].
Dual-energy computed tomography (DECT) is an advanced form of CT in which image acquisition is performed at 2 different energies. This technology allows tissue characterisation through material decomposition and voxel-to-voxel determination of iodine concentration, which can be used to derive a regional blood volume map [18,19]. The applications of DECT in head and neck cancer have been a growing area of interest, with several recent studies showing the benefit of iodine characterisation and virtual monoenergetic images for detection and delineation of head and neck tumor [20,21], differentiation between metastatic, inflammatory and benign cervical lymph nodes [22,23] or assessment of cartilage invasion [24,25]. However, the role of DECT-derived quantitative imaging to predict oncological outcomes in HNC has never been previously investigated. Yet the rich quantitative information provided by DECT offers a unique opportunity for functional biomarker analysis. As previously proposed in single energy CT studies [26], we hypothesized that higher tumor iodine content is indicative of increased blood volume and capillary hyperpermeability associated with neo-angiogenesis. The purpose of this study was to investigate the role of DECT-derived quantitative histogram analysis of pre-treatment for prediction of LRR in patients with L/H SCC.
Section snippets
Patient population
Patients with larynx or hypopharynx cancer treated with radiotherapy and that underwent a pre-treatment planning DECT between January 2015 and August 2016 at our institution, were included in this retrospective study. Inclusion criteria were: [1] histological diagnosis of SCC of the larynx or hypopharynx [2]; curative intent locoregional radiotherapy +/- concurrent chemotherapy; [3] pre-treatment contrast-enhanced planning DECT of the neck. Patients that received induction chemotherapy and had
Patients and treatments characteristics
In total, 25 patients met inclusion criteria. Twenty-five patients, including 20 supraglottic and 5 pyriform sinus tumors were analysed; 76% were male. Median age was 65 years (43–79). Median GTVp volume was 7.9 cm3 (range = 0.7–51.8 cm3) and median GTVn volume was 7.0 cm3 (range = 0.5–25.8 cm3). Stage I, II, III, IVa and IVb constituted 4% (1 patient), 24%, 36%, 28% and 8% of patients, respectively. Forty-four percent had concurrent cisplatin and 28% had neoadjuvant chemotherapy consisting of
Discussion
This pilot study explores the role of DECT-derived quantitative imaging for outcome prediction in HNC. In this study, we describe a method allowing for volumetric extraction of iodine fraction from each voxel of the primary tumor and involved lymph nodes in L/H SCC. Iodine concentration was used as a surrogate for regional blood volume, with the working hypothesis that increased tumor angiogenesis would result in higher iodine contrast enhancement, as previously supported in single energy CT
Conflicts of interest
This work was supported by Fonds de Recherche du Québec-Santé. Houda Bahig, Edith Filion and David Roberge received research grant from Varian Medical Systems, unrelated to current work. Houda Bahig and David Roberge received speakers Honoraria from Siemens Healthineers/Varian Medical Systems, unrelated to current work.
References (46)
- et al.
Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary
Int. J. Radiat. Oncol. Biol. Phys.
(2009) - et al.
Systematic review on T3 laryngeal squamous cell carcinoma; still far from a consensus on the optimal organ preserving treatment
Eur. J. Surg. Oncol.
(2017) - et al.
Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891
Ann. Oncol.
(2012) - et al.
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial
Radiother. Oncol.
(2012) - et al.
Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma
Radiother. Oncol.
(2014) - et al.
Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy
Int. J. Radiat. Oncol. Biol. Phys.
(2003) - et al.
Perfusion CT of head and neck cancer
Eur. J. Radiol.
(2014) - et al.
Advanced tissue characterization and texture analysis using dual-energy computed tomography: horizons and emerging applications
Neuroimaging Clin. N. Am.
(2017) - et al.
Can dual-energy CT improve the assessment of tumor margins in oral cancer?
Oral Oncol.
(2014) Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review
Eur. J. Radiol.
(1999)
Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma
Radiother. Oncol.
Causes and effects of heterogeneous perfusion in tumors
Neoplasia
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer
Int. J. Radiat. Oncol. Biol. Phys.
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
Int. J. Radiat. Oncol. Biol. Phys.
Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study
Int. J. Radiat. Oncol. Biol. Phys.
Dual energy CT in radiotherapy: current applications and future outlook
Radiother. Oncol.
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
N. Engl. J. Med.
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer
J. Clin. Oncol.
Cancer statistics
CA Cancer J. Clin.
Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma
Eur. Radiol.
Multiparametric Imaging of Tumor Hypoxia and Perfusion with (18)F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer
J. Nucl. Med.
Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma
Acta Oncol.
Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI
J. Nucl. Med.
Cited by (38)
The value of dual-layer spectral detector CT in preoperative T staging of laryngeal and hypopharyngeal squamous cell carcinoma
2024, European Journal of RadiologyAdvanced CT and MR Imaging of the Posttreatment Head and Neck
2022, Neuroimaging Clinics of North America